MEMORIAL DAY FLASH SALE: 50% OFF BENZINGA PRO
As we honor our freedom, take a stand today. Secure the financial freedom that both you and your family deserve. Get exclusive market moving news for just 50% off. Claim your 50% discount here.
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) shares have traded up 45 percent in the last six months, and the Vetr community has downgraded the stock from 3.5 stars to 3 stars.
The stock is down about seven handles since its underwhelming first-quarter earnings report on May 9.
See how crowdsourced ratings can help predict the market?
Vetr members have given Jazz Pharma a Hold rating and $156.97 price target. This price target is lower than the $182.93 price target from Wall Street analysts. The company opened Tuesday around $149.
Of all Vetr raters, about 43 percent believe traders and investors should buy Jazz Pharma stock.
For Vetr’s full analysis of Jazz Pharma, go here.
MEMORIAL DAY FLASH SALE: 50% OFF BENZINGA PRO
As we honor our freedom, take a stand today. Secure the financial freedom that both you and your family deserve. Get exclusive market moving news for just 50% off. Claim your 50% discount here.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!